Liver conditions Flashcards

1
Q

Describe the architecture of a liver lobule

A

Histologically, the liver is composed of hepatocytes, bile canaliculi, and hepatic sinusoids:

  • Hepatocytes are arranged in chords, with blood flowing inbetween in sinusoids from the portal triads → central vein
  • Endothelial cells form space of Disse between hepatocytes and sinusoids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the roles of the several vessels entering or leaving the liver

A
  • Portal vein bringing food-rich blood from the gut.
  • Hepatic artery bringing oxygenated arterial blood. Liver has dual blood supply.
  • Heptic veins taking away processed blood into the vena cava.
  • Lymphatics taking away some lymph and some by-products.
  • Hepatic ducts removing bile to the gallbladder & gut (biliary system).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe the general anatomical features of the liver

A
  • Large, lobated exocrine/blood-processing gland, with vessels/ducts entering/leaving at the porta
  • Enclosed by a thin collagen tissue capsule, mostly covered by mesothelium.
  • Collagen tissue of the branching vascular system provides gross support.
  • Parenchymal cells are supported by fine reticular fibres.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the hepatic lobular flow

A

Blood flows:

  1. From branches of the portal vein and hepatic artery; from the periphery towards the centre;
  2. in the sinusoids, between the cell plates (blood flows slowly from portal triad to central vein, allowing exchange of nutrients for the enrichment of blood)
  3. Blood collected in central veins → sublobular veins → collecting veins → hepatic veins leaving the liver.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe the liver acinus

A

The territory of an acinus (as its axis) has one final branch

of the portal vein, and is subdivided into:

  1. Periportal zone – roughly spheroid, isolated from periportal zones of adjacent acini
  2. Intermediate zone
  3. Perivenous zones – near the central vein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does this slide show?

A

Normal liver

No fatty infiltration

No inflammation

No fibrosis or cell plate thickening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What types of cells are found within the sinusoids of the liver?

A

Kuppfer (stellate) cells- resident liver macrophages

Under physiological conditions, they are the first innate immune cells and protect the liver from bacterial infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Roughly speaking, what do the 3 main LFTs measure?

A

LFTs measure liver enzymes which can leak from damaged liver cells- so they reflect liver injury

  • ALT + AST = liver parenchymal damage (hepatocellular)
  • ALP = obstructive cause (cholecystatic)

Gamma-GT = mirrors ALP (unlike ALP, only produced by liver so good way of discerning hepatic pathology)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

State the sources of ALT, AST, ALP

A

ALT = hepatocytes ONLY

AST = liver, heart, skeletal muscle, kidneys, pancreas

ALP = biliary ducts, bone, placenta, small intestine, kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the correct way of assessing ALT and AST levels? Explain which pathologies would affect assessment of AST:ALT

A

must look at AST:ALT ratio

High AST:ALT >2.5 = alcoholic damage/cirrhosis, metastases

Low AST:ALT <1 = paracetamol OD (toxin-induced hepatitis), viral hepatitis (hep A/B/E, EBV, CMV), hepatic obstruction

SALT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Compare the likely diagnoses for a:

  1. Marked
  2. Moderate
  3. Mild

increase in ALT

A

Marked increase (1000s):

  • Toxin/drug induced hepatitis e.g. paracetamol
  • Acute viral hepatitis e.g. hep A/B/E, EBV, CMV

Moderate increase (300-500):

  • chronic/alcoholic/autoimmune hepatitis
  • biliary obstruction

MIld increase (<300):

  • Cirrhosis
  • Haemachromotosis
  • hepatocellular carcinoma
  • Wilson’s
  • NASH
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

State some non-hepatic causes for raised ALP

A
  • placenta: pregnancy
  • small intestine: fatty meals
  • kidney: CKD
  • bone: paget’s, bony metastases, fractures, osteomalacia, renal bone disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which marker can be measured to determine whether ALP is hepatic in origin?

A

Gamma-glutamyl transferase (Gamma-GT)

Mirrors ALP but specific to liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

And isolated rise in Gamma-GT is suggestive of what?

A

alcoholic liver disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is a high ALP with high gamma-GT suggestive of?

A

bile duct disease

liver metastases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Summarise the production of bilirubin

A

reticuloendothelial cells metabolise Hb into haem and globin

haem → iron and bilviderin

bilviderin → unconjugated bilirubin (binds to albumin and travels to liver)

conjugated bilirubin excreted into bile

in colon: conjugated bilirubin → urobiligen (20% absorbed via enterophepatic circulation)

80% urobiligen → stercobilin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How can jaundice be categorised? For each, state the underlying cause and the type of bilirubin that is in excess

A

Pre-hepatic = increased haemolysis = ^UNCONJUGATED

Heptic =liver impairment = ^UNCONJUGATED+CONJUGATED

Post-hepatic = biliary tree obstruction = ^CONJUGATED

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

EXPLAIN the causes of pre hepatic jaundice

A

Caused by increased haemolysis.

This results in the increased presence of unconjugated bilirubin in the blood as the liver is unable to conjugate it all at the same rate.

This is caused by:

  • Tropical disease, e.g. malaria, yellow fever
  • Genetic disorders, e.g. sickle-cell anaemia, Gilbert’s syndrome
  • Haemolytic anaemias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

EXPLAIN the causes of hepatic jaundice

A

Hepatic jaundice is caused by liver impairment.

This causes the decreased ability of the liver to conjugate bilirubin, resulting in the presence of conjugated and unconjugated bilirubin in the blood. Liver damage can result from:

  • Viral hepatitis
  • Hepatotoxic drugs, e.g. paracetamol overdose, alcohol abuse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

EXPLAIN the causes of post hepatic jaundice

A

Post-hepatic jaundice is caused by the blockage of bile ducts.

This results in backflow of conjugated bilirubin into the blood as it cannot move past the obstruction.

Bile duct obstruction can be caused by:

  • Gallstones
  • Hepatic tumours
  • Pancreatic tumours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the key liver protein and what is a specific outcome of not having enough

A

Albumin

When albumin is low, there is reduced oncotic pressure so water leaks out of cells contributing to ascites.

May be low due to low production or increased loss (nephrotic syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

State some pathologies that cause:

  1. Low albumin + low protein
  2. Low albumin + normal protein
  3. Low albumin + high protein
A
  1. Low albumin + low protein =
    • advanced cirrhosis
    • protein malnutrition
    • chronic inflammation
  2. Low albumin + normal protein =
    • infection
  3. Low albumin + high protein =
    • myeloma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

State some causes of raised INR

A
  • liver disease with impaired function
  • vit K deficiency
  • consumptive coagulopathy (DIC)
  • overdose of oral anticoagulants (VKAs)
  • Coagulation factors deficiency (fibrinogen and factors II, V, VII, or X, or a combined deficiency) in the extrinsic pathway
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Define Liver Abscess and Liver Cyst

A

Localised infection in the liver parenchyma that may be bacterial, fungal, or parasitic in origin…

resulting in a walled off collection of …

  1. abscess = pus
  2. cyst = cystic fluid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

State the common causative oganisms for liver abscesses and cysts

A

Pyogenic (producing pus)

  • E. coli
  • K. pneumoniae
  • S. constellatus
  • Klebsiella species
  • Streptococcus

Anaerobes:

  • Bacteroides fragilis
  • Fusobacterium necrophorum

Amoebic abscess

  • Following infection by Entamoeba histolytica
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Which antimicrobial agent would be a good choice in treating an amoebic liver abscess?

A

metronidazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What is the optimal management of a non-amoebic liver abscess?

A

drainage + antibiotic therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Liver abscesses form by spread of infection from which sources?

A
  • Biliary tree
  • Portal vein
  • Hepatic vein
  • Penetrating trauma
  • Extension of contiguous infection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

What is the most common identifiable source of pyogenic liver abscess?

A

The biliary tract

cholecystitis, colangitis, strictures, congenital cysts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

State the most common causes of liver abscess

A

40% of cases = idiopathic

Infective abscesses:

  • Cholecystitis, cholangitis
  • caused by pyelophlebitis:
    • appendicitis
    • diverticulitis
    • IBD
    • pancreatitis
  • Immunocompromise
  • diabetes mellitus

Malignant/parenchymal abscesses:

  • Primary hepatocellular cancer + liver mets
  • Cirrhosis

Iatrogenic abscesses

  • Post-transplant
  • chemoembolisation or percutaneous ablation of hepatic neoplasms
  • Biliary sphincterotomy
  • hepatic cryotherapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Summarise the epidemiology of liver abscesses and cysts

A

Uncommon- annual incidence is approximately 3.6/100,000

Pyogenic = most common in the industrialised world

Amoebic liver abscess - most common WORLDWIDE

Hydatid cysts - common in sheep-rearing countries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

What are the presenting symptoms of liver abscess?

A

Acute onset in amoebic abscess, insidious in pyogenic:

  • Fevers and chills
  • RUQ pain/tenderness
  • weight loss, anorexia
  • N+V
  • fatigue
  • chest symptoms: cough, SOB, pleuritic chest pain
    • due to diaphragmatic inflammation
    • may see reactive pleural effusion in right lower lobe
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Why is it important to ask about travel when taking a history for suspected liver abscess?

A

Strongly associated risk factor for amoebic liver abscess:

origin in or having visited endemic areas for amoebiasis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

What are the signs of liver abscesses and cysts on physical examination?

A
  • Fever - continuous or spiking
    • Pyogenic abscess should be considered in all patients presenting with pyrexia of unknown origin associated with associated abdominal pain or bloating
  • Tender hepatomegaly (right lobe affected more than left)
  • Signs of reactive pleural effusion:
    • Dullness to percussion (RHS)
    • Reduced breath sounds (RHS)
  • If the abscess ruptures (a rare complication), then patients may present with signs of shock.​
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Identify appropriate investigations for liver abscesses and cysts

A
  1. Bloods
    • FBC- leukocytosis
    • LFTs- raised ALP, ALT and bilirubin
    • Blood and fluid cultures
    • PTT + APTT - prior to aspiration, check for deranged clotting factors
  2. Liver USS (80-90% sensitive)
    • poor-defined lesions with hypo- and hyper-echoic areas
    • guide aspiration
  3. CT abdo contrast (>95% sensitive)
    • lesion seen with surrounding oedema
    • gas within lesion highly sugestive of pyogenic abscess
  4. Gram stain and culture of aspirated abscess fluid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Describe the stages of ALD

A

Alcoholic liver disease (ALD) has 3 stages of liver damage:

  1. fatty liver (steatosis)
  2. alcoholic hepatitis (inflammation and necrosis)
  3. alcoholic liver cirrhosis

All are caused by chronic heavy alcohol ingestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What are the defining and associated histopathological features of alcoholic hepatitis?

A

defining histological features:

  • hepatocyte degeneration and necrosis
  • inflammation
  • fibrosis

associated histological features:

  • fatty change- steatosis
  • megamitochondria
  • Mallory-hyaline inclusions (eosinophilic intracytoplasmic aggregates of cytokeratin intermediate filaments)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

What does the following slide show?

A

Histochemical liver stain- collagen staining blue

Shows a fatty liver with scarring, inflammation and damage

Swollen balloon cells, inflammatory cells

Mallory hyaline bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

What does the following slide show?

A

Disorganised- hepatocytes are not arranged in a trabecular fashion- this is a sign of liver damage

clear spaces = steatosis = fatty cells

arrows pointing at mallory hyaline = hepatocyte damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

What is another cause of fatty buildup in the liver apart from alcoholic liver disease?

A

Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver.

  • Newly emerging issue
  • Patients with insulin resistance
  • Due to obesity epidemic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

What is the name of the condition in ALD where bile cannot flow from the liver to the duodenum?

A

cholestasis

red is bile

inflammation/obstruction disturbs bile flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Summarise the epidemiology of alcoholic hepatitis

A

In the UK, 24-28% of adults drink in a harmful way.

alcoholic hepatitis occurs in 10-35% of heavy drinkers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

What are the presenting signs and symptoms of chronic liver disease?

A

A long history of heavy drinking is required for ALD development (15-20yrs)

Key features:

  • RUQ abdominal pain
  • Hepatomegaly

Other features:

  • Haematemesis/melaena- from oesophageal/gastric varices + coagulopathy
  • caput medusae
  • splenomegaly
  • ascites /abdo distention
  • asterixis
  • Testicular atrophy​
  • spider naeviae- cutaneous telaniectasia
  • jaundice
  • palmar erythema
  • gynaecomastia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

State the 5 primary causes of liver disease

A
  • Alcohol
  • Autoimmune
  • Drugs
  • Viral
  • Biliary disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

What are the symptoms of acute liver disease?

A

There may be triggering events (e.g. aspiration pneumonia, trauma)

  • Malaise
  • Anorexia / N+V
  • Fever
  • Jaundice
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

What are the signs of encaphalopathy, such as that caused by ALD? What is this caused by ?

A

Signs:

  • asterixis
  • drowsiness
  • disorientation

Cause:

  • Build up of ammonia in the blood - inadequate hepatic clearance
  • This crosses the BBB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Explain the blood results in alcoholic hepatitis

A

FBC:

  • Low Hb- iron / folate deficiency, GI bleeding, haemolysis, hypersplenism
  • High MCV
  • Leukocytosis- alcoholic hepatitis-related leukaemoid reaction or associated infection.
  • Thrombocytopenia- 2/2 alcohol-induced bone marrow suppression, folate deficiency, or hypersplenism.

LFTs:

  • Low albumin
  • Prolonged PT (longer = more damage)
  • High AST + ALT- found in hepatocytes
  • High bilirubin
  • elevated GGT- more sensitive than ALT/ALP, less specific

U&Es:

  • Normal or low sodium, potassium, magnesium, phosphorus
  • elevated urea- suggests active GI bleeding when paired with normal creatinine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

What does the AST:ALT ratio tell us about the cause of hepatitis?

A

Raised AST= AST>ALT (ratio >2) = alcoholic cause

Raised ALT= ALT>AST (ratio <1)= viral, non-alcoholic fatty liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

In what conditions is AST raised?

A

present in heart, muscle, kidney and brain

raised in:

  • MI
  • hepatic necrosis
  • muscle injury
  • congestive cardiac failure
  • ALD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

In what conditions are ALT and AST raised?

(very raised → mildly raised)

A

Indicate hepatocellular injury

+++ = viral, toxic or alcoholic hepatitis (<50x), ALT>AST

++ = cirrhosis and other chronic liver diseases (<5x) AST>ALT

+ = obstructive jaundice (<3x)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

State some non-bedside investigations for alcoholic hepatitis

A
  • Ultrasound - used to screen for HCC every 6-12 months in ALD patients with cirrhosis.
  • Upper GI Endoscopy - investigate varices
  • Liver Biopsy - diagnostic of ALD and/or alcoholic cirrhosis
  • EEG - slow-wave activity indicates encephalopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

How would you manage acute hepatitis?

A
  • Thiamine
  • Vitamin C and other multivitamins (Pabrinex)
  • Monitor and correct K+, Mg2+ and glucose
  • Ensure adequate urine output
  • Steroid therapy for prevention of short-term mortality- prednisolone
  • Glypressin and N-acetylcysteine for hepatorenal syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

How would you provide nutrition to those with acute alcoholic hepatitis?

A

Via oral or NG feeding is important

Protein restriction if encephalopathic

Parenteral nutritional supplementation (B group, thiamine and folic acid)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

How would you treat ascites and encephalopathy caused by ALD?

A

Encephalopathy:

  • oral lactulose or phosphate enemas
  • decrease ammonia generation by bacteria

Ascites:

  • diuretics (spironolactone with/without furosemide)
  • therapeutic paracentesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

What management should be taken to slow the progression of ALD?

A
  • alcohol abstinence +/- withdrawal management
    • lond-acting benzodiazepines- oxazepam/diazepam for seizure prevention.
    • May worsen encephalopathy
  • weight reduction and smoking cessation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Explain 2 syndromes arising from live failure caused by activation of RAAS

A

portal hypertension

splanchnic vasodilation (increased NO)

reduced blood volume detected in JGA

activation of RAAS

2 outcomes:

  1. vasoconstriction of renal vessels ⇒ HEPATORENAL SYNDROME
  2. Renin stimualtes reabsorption of salt + water ⇒ ASCITES
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Identify the possible complications of alcoholic hepatitis

A
  • hepatic encephalopathy
  • portal hypertension
  • hepatorenal syndrome
  • GI bleeding 2/2 gastro-oesophageal varices, haemorrhoids, and portal hypertensive gastropathy + coagulopathy
  • hepatocellular carcinoma
  • sepsis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

Summarise the prognosis for patients with alcoholic hepatitis

A

Mortality:

  • First month = 10%
  • First year = 40%

If alcohol intake continues, most will progress to cirrhosis within 1-3 years

To calculate prognostic score can use Maddrey’s discriminant function or Glasgow alcoholic hepatitis score

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Define autoimmune hepatitis

A

Chronic inflammatory disease of the liver of unknown aetiology.

Characterised by:

  • presence of circulating auto-antibodies with a high serum globulin concentration
  • inflammatory changes on liver histology
  • favourable response to immunosuppressive treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

What are the risk factors for autoimmune hepatitis?

A
  • female gender
  • genetic pre-disposition
    • HLA- different for types 1+2
  • immune dysregulation
    • ​other autoimmune condtions
  • Viruses:
    • measles virus
    • cytomegalovirus
    • Epstein-Barr virus
    • hepatitis viruses A, C, and D
  • certain drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Explain the aetiology of autoimmune hepatitis

A
  1. Genetic predisposition + environmental factor
  2. hepatocyte production of HLA antigensT-cell-mediated autoimmune attack
  3. Chronic inflammatory changes- lymphoid infiltration of the portal tracts
  4. hepatocyte necrosis → fibrosis → cirrhosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

Summarise the epidemiology of autoimmune hepatitis

A

Type 1 (commonest): occurs in ALL age groups (but mainly young women)

Type 2: generally occurs in girls and young women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

What are the presenting symptoms of autoimmune hepatitis

A

May be asymptomatic and discovered incidentally through abnormal LFT

non-acute:

  • fatigue/malaise
  • abdominal discomfort
  • nausea
  • arthralgia involving small joints
  • anorexia
  • spider angiomata
  • pruritus

acute(25):

  • fever
  • jaundice
  • N+V, diarrhoea
  • Some may present with serum sickness (e.g. arthralgia, polyarthritis, maculopapular rash)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

What are the signs of autoimmune hepatitis on physical examination?

A

Stigmata of chronic disease:

  • spider naevi
  • palmar erythema
  • jaundice
  • hair loss
  • leuconychia
  • asterixis

Ascites, oedema and hepatic encephalopathy are late features

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Identify appropriate investigations for autoimmune hepatitis

A

Bloods:

  • LFTs
    • high AST, ALT, bilirubin, gamma- GT (not as much as bile duct injury)
    • ALP not usually raised much
    • hypoalbuminaemia
  • Hypergammaglobulinaemia is typical with:
    • Presence of ANA, ASMA and Anti-LKM antibodies
  • increased PTT

Liver Biopsy:

  • Needed to establish diagnosis and check whether hepatitis or cirrhosis

US, CT or MRI of liver and abdomen

  • Visualise structural lesions

ERCP

  • To rule out PSC
66
Q

What blood antigens are tested in suspected autoimmune hepatitis to rule out other causes of liver damage?

A
  • Viral serology (hep B/C)
  • Urinary copper/caeruloplasmin (Wilson’s disease)
  • Ferritin and transferrin saturation (haemochromatosis)
  • a-1 antitrypsin (for deficiency)
  • Anti-mitochondrial antibodies (PBC)
67
Q

What are the indications for management of autoimmune hepatitis?

A

Aminotransferases > 10x the upper limit of normal

Symptomatic

Histology: significant interface hepatitis, bridging necrosis or multiacinar necrosis

68
Q

How is autoimmune hepatitis managed?

A

Immunosuppression:

  • corticosteroids eg prednisolone
    • maintenance treatment with gradual reduction in dose
  • immunosupressive agents eg azathioprine, mercaptopurine
    • for maintenance phase
    • steroid sparing agents

Monitor

  • Ultrasound and alpha-fetoprotein level every 6-12 months in patients with cirrhosis – to detect hepatocellular carcinoma
  • Repeat liver biopsies to check disease progression

Hep A and B vaccinations

Liver transplant

  • If patient refractory/intolerant to immunosuppression therapy/end-stage of disease
69
Q

What are the possible complications of Autoimmune Hepatitis

A
  • Fulminant hepatic failure – severe impairment of hepatic functions in the absence of pre-existing liver disease
  • Cirrhosis
  • Complications of portal hypertension – varices, ascites
  • Hepatocellular carcinoma
  • Side-effects of corticosteroid treatment
70
Q

What is the prognosis for patients with autoimmune hepatitis?

A

80% achieve remission by 3 years

35-50% remain in remission when immunosuppression withdrawn

50% require lifelong maintenance

5 year survival rate: 85% if treated, 50% if untreated

71
Q

Define viral hepatitis

for A - E, state whether infection is acute or chronic

A

hepatitis caused by infection with RNA viruses

  • hepatitis A + E = acute only
  • hepatitis B + D = acute or chronic (D requires infection with B)
  • hepatitis C = chronic only
72
Q

Explain the aetiology of hepatitis A + E

A

Small non-enveloped single-stranded RNA viruses

  1. Transmission = faecal-oral route
  2. Viruses replicate within hepatocytes and are secreted into bile
  3. Infected hepatocytes are targeted by CD8+ T cells and NK cellsnecrosis + liver inflammation
73
Q

What is the average incubation period for HAV?

A

28 days.

74
Q

What are the key histological features of viral hepatitis?

A
  • Inflammatory cell infiltration of portal tracts (neutrophils, macrophages, eosinophils, lymphocytes)
  • Zone 3 necrosis
  • Bile duct proliferation
75
Q

Summarise the epidemiology of HAV/HEV in the developed and developing worlds

A

Developing world:

  • HAV is endemic - Asia, Africa and Central America
  • Infection often occurs sub-clinically (asymptomatic in young children)
  • children are key transmission reservoir

Developed world:

  • Less common (better sanitation)
  • Age of exposure is higher → patients = symptomatic
  • Annual UK incidence: 5000
76
Q

What are the 3 phases of hepatitis A+ E? For each phase, state the symptoms

A

Prodromal phase- abrupt onset pre-jaundice (1 week)

  • Anorexia
  • Fever
  • N+V
  • Malaise, fatigue
  • Distaste for cigarettes in smokers
  • Headache

Icteric phase (1-4 weeks)

  • Jaundice
  • Tender hepatomegaly
  • RUQ pain
  • Pale stools + dark urine
    • ​acholic stools = clay coloured
  • Pruritis

Recovery/convalescence phase

  • 1-2 weeks after jaundice
  • Full recovery takes 4-6 weeks

note the ABSENCE of stigmata of chronic liver disease (although some spider naevi may appear transiently)

77
Q

Identify appropriate investigations for viral hepatitis

A
  1. LFTs
    • high AST, ALT and bilirubin
    • ALP mildly raised
    • low albumin
  2. FBC, coagulation profile, U+Es
    • microcytic anaemia, thrombocytopaenia
      • due to cirrhosis-induced portal hypertension
    • other signs of cirrhosis- high PTT, high urea, hyponatraemia
  3. Viral serology
    • IgM HAV / IgM HEV - shows current infection (IgG shows past)
    • Hepatitis B surface antigen -HBsAg (HB antibody shows past)
    • HCV antibody test
    • HEV in stool
  • Urinalysis
    • Positive for bilirubin
    • Raised urobilinogen
78
Q

How is viral hepatitis A+E managed?

A

Largely supportive:

  • If exposed to HAV - vaccine ASAP and/or immunoglobulin for high risk - no HEV vaccine
  • avoid alcohol + hepatotoxic drugs eg paracetamol
  • hospitalisation rarely- for volume depletion, coagulopathy, encephalopathy, severe prostration
  • <1% need transplant
79
Q

Summarise the prognoses for viral hepatitis A+E

A
  • Recovery is usually within 4-8 weeks
  • 85% full recovery in 3 months
  • 10-20% relapse w/ persistent fever, jaundice etc over several months
  • In pregnancy HEV can cause fulminant hepatic failure- mortality of 80%
  • No chronic effects
80
Q

What are the possible complications of viral hepatitis A+E?

A
  • Fulminant hepatic failure (in a very small proportion of patients but is more common in pregnant women)
  • Cholestatic hepatitis with prolonged jaundice and pruritus can develop after HAV infection
  • Post-hepatitis syndrome: continued malaise for weeks to months
81
Q

compare the genomic structure of viral hepatitis B,C,D

A

HCV = flavivirus, single-stranded, enveloped RNA

HBV = hepadnavirus, double-stranded, enveloped DNA

HDV= single-stranded RNA virus coated with HBsA

defective virus, using the HBV surface antigen to enter hepatocytes

82
Q

Which is the most severe form of chronic hepatitis?

A

Hepatitis delta virus (HDV)

HDV-infected individuals are more likely to die from advanced liver disease compared with HBV alone

Their risk of developing hepatocellular carcinoma is 9x higher.

83
Q

How are hepatitis B and C transmitted?

A
  • percutaneous blood exposure
    • (unsafe healthcare practices, IV drug use)
  • sexual transmission
  • perinatally- permucosal transmission from HB/CV infected mother (vertical transmission)
84
Q

State the risk factors for hepatitis B and C

A
  • perinatal exposure in an infant born to an HBV-infected mother
  • high-risk sexual behaviours
  • unsafe medical practices
    • most common worldwide cause is unsafe injection practices
    • unscreened blood transfusion
  • IV/intranasal drug use
  • family history of HBV, hepatocellular carcinoma, and/or chronic liver disease
    • genetic factors are associated with varying rates of viral clearance

younger individuals (particularly babies) are more likely to become chronic carriers​

incarceration increases risk of the above risk factors

85
Q

Summarise the epidemiology of hepatitis B + C

A
  • HCV = 71 million infected. Worldwide endemic
    • European and Eastern Mediterranean
  • HBV = 250-350 million infected. Endemic only in LICs
    • Southeast Asia (excluding Japan), China, and Africa
86
Q

What are the 3 viral proteins produced by HBV that can be measured? What does their presence indicate?

A
  • Core antigen (HBcAg)
    • test looks for antibody to the antigen rather than antigen itself
  • Surface antigen (HBsAg)
    • indicates active infection
    • detected an average of 4 weeks post-exposure
    • usually becomes undetectable after 4-6 months of infection.
  • e antigen (HBeAg)
    • acute phase protein
    • presence ≥3 months after onset = high likelihood of development of chronic infection
    • indicates greater infectivity, with a high level of viral replication

ANTIBODIES TO ANY OF THESE ANTIGENS INDICATE CLEARED/ACTIVE/CHRONIC INFECTION

87
Q

How is HDV detected?

A

Presence of anti-HDV antibodies using PCR

88
Q

Other than serology tests can be done in suspected/diagnosed viral hepatitis?

A

Abo USS- all patients

  • evaluate for fibrosis, cirrhosis, portal hypertension + HCC

Liver biopsy

  • patients with chronic infection to grade and stage liver disease before initiating therapy
  • rule out other causes

Non-invasive tests of liver fibrosis

  • liver elastography uses ultrasound and low-frequency waves to measure liver elasticity
89
Q

How is hepatitis B and C managed?

A

Immunisation

  • active = recombinant HBsAg (at risk individuals, neonates with HBV+ mothers)
  • passive = HB immunoglobulin/antibodies (post-exposure)

Symptomatic Tx

  • acutely eg antipyretics, antiemetics and cholestyramine

Antiviral therapy

  • entecavir, TDF, TAF, interferon-alpha
  • see algorithm for indications
  • usually life-long
  • Nucleoside/nucleotide analogues. entecavir is a cytokine
90
Q

Identify the possible complications of viral hepatitis B + C

A
  • 1% get fulminant hepatic failure
    • Massive immune-mediated lysis of infected hepatocytes
  • Chronic HBV infection (10% of adults, much higher in neonates)
  • Cirrhosis- 20% of chronic patients, exacerbated with alcohol
  • HCC (HBV accounts for 50% HCC worldwide)
    • results from chronic inflammation and cellular regeneration

Extrahepatic immune complex disorders

  • ​rheumatological complications
    • myalgia, fatigue, arthralgias, and arthritis.
  • skin complications
    • porphyria cutanea tarda and lichen planus.
  • cryoglobulinaemia
    • Cryoglobulins deposit in the skin, kidney, and joints
  • glomerulonephritis
  • eye complications
91
Q

Define hepatocellular carcinoma

A

Primary malignancy arising from hepatocytes in predominantly cirrhotic liver.

However, some patients may not have cirrhosis before developing HCC (esp chronic HBV)

92
Q

What is the prognosis for hepatitis B?

A
  1. ‘Full recovery’.
    • Majority, HBV is a self-limiting condition with full clinical recovery.
    • Virus is rarely cleared completely but kept in check by cytotoxic T-cells.
    • (immunosuppresion can lead to reactivation)
  2. Carrier status.
    • 10% will become asymptomatic carriers (virus still detectable in the blood)
    • Long-term prognosis is good
    • risk of long-term complications <1%.
  3. Chronic hepatitis B. (symptomatic)
    • 5–10%
    • Rates are 90% if the infection was acquired at birth from the mother.
    • Of the patients who develop chronic infection, about 20% will develop cirrhosis and 6% HCC
  4. Fulminant hepatitis.
    • 0.5%
    • mortality rate of 80%
93
Q

What are the risk factors for HCC?

A

Chronic liver damage

  • cirrhosis
  • chronic hepatitis B and C
  • chronic heavy alcohol use >80 g/day for more than 10 years
  • Diabetes and obesity- insulin resistance
  • FHx
  • Aflatoxin
  • Haemachromotosis (iron overload in liver)
94
Q

Summarise the epidemiology of hepatocellular carcinoma

A
  • COMMON- 6th most common worldwide
  • average age = 60
  • LESS common than liver metastases
  • High incidence in regions where hepatitis B and C are endemic
  • 44% of HCC cases worldwide are attributable to chronic HBV infection
95
Q

What are the presenting symptoms of HCC?

A

Symptoms of Malignancy

  • Malaise
  • Weight loss
  • Loss of appetite

Symptoms of chronic liver disease (cirrhosis):

  • RUQ pain- enlarged liver, liver inflammation, and stretching of the liver capsule.
  • early satiation- compression of ascites on stomach
  • abdominal distension - ascites
  • jaundice
  • oesophageal or gastric variceal bleeding
  • leg oedema
  • cachexia
  • asterixis, palmar erythema, spider naevi, caput medusae
96
Q

What management options are available for HCC?

A
  • Hepatic resection
  • Liver transplantation
  • Radiofrequency ablation (RFA)- destroys the tumour by modifying the temperature
97
Q

How would bloods would you do to investigate HCC? What would they show?

A
  • FBC- microcytic anaemia, thrombocytopaenia
    • due to variceal bleeding and portal hypertension (splenic sequestration + pooling of blood)
  • U+Es- hyponatraemia, high urea due to renal injury
  • LFTs- elevated AST/ALT, ALP, and bilirubin; low albumin
  • Clotting- eleveated PTT
  • AFP- elevated in 60% HCC patients.
    • Tumour marker
98
Q

What other investigations other than bloods would you do for HCC?

A
  • Abdo USS- initial staging test + cirrhosis screening every 6 months
    • sensitive but not specific
    • see irregular echos and poorly defined margins
  • CT/MRI abdo w/contrast
    • more specific than USS
    • used if AFP raised/abnormal USS
  • Liver biopsy
    • not required in majority- radiological diagnosis
    • see central necrosis, multinucleated giant cells, poorly differentiatd hepatocytes
99
Q

Define NASH

A

Clinico-histopathological entity that includes a spectrum of conditions

characterised histologically by macrovesicular hepatic steatosis in those who do not consume alcohol in amounts generally considered harmful to the liver

100
Q

Explain the pathophysiology of NASH

A

HIT 1

insulin resistanceexcessive triglyceride accumulation → hepatic steatosis

HIT 2

additional oxidative injury/stress → necroinflammatory changes → steatohepatitis (inflammation and fibrosis)

multifactorial causes, including dysregulated cytokine production, hormones, deficiencies and intestinal bacteria

101
Q

What does NASH increase the risk of?

A

diabetes mellitus

MI

stroke

102
Q

What are the risk factors for NASH?

A
  • obesity
  • insulin resistance or diabetes
  • hyperlipidaemia
  • hypertension
  • metabolic syndrome
  • history of rapid weight loss
  • hepatotoxic medications- oestrogens (tamoxifen), corticosteroids, methotrexate
  • total parenteral nutrition
  • increasing age
103
Q

Summarise the epidemiology of NASH

A

Difficult to ascertain- need biopsy (not USS) in order to make the diagnosis.

MOST COMMON liver disorder in developed countries

1/3 people in the UK have the early stages of NASH

104
Q

What are the signs and symptoms of NASH?

A

Early stages are usually asymptomatic

  • fatigue and malaise
  • heptosplenomegaly
  • truncal/central obesity
  • RUQ discomfort (dull, aching)

Symptoms of cirrhosis will be experienced in the most advanced stages of NASH

105
Q

What investigations are undertaken for NASH?

A

LFTs-

  • mildly elevated ALT/AST 1-4x normal
  • AST:ALT ratio = <1 (in acute alcoholic, usually >2)
  • mildly elevted/normal bilirubin, ALP, GGT

FBC-

  • anaemia, thrombocytopaenia in advanced disease (due to hypersplenism)

Metabolic panel

  • hyperglycaemia- due to insulin resistance
  • hyperlipidaemia in lipid panel

Liver Ultrasound

  • specific and sensitive
  • diffuse hyperechoic echotexture (bright liver)

Liver Biopsy

  • ultimately required for diagnosis

Abdo MRI/CT

  • Show decreased liver attenuation and increased fat content
106
Q

How is NASH managed?

A

CONSERVATIVE- need to control risk factors

  • diet and exercise
    • reduced alcohol
    • reduced cholesterol
    • stop smoking
  • vitamin E- improve liver function
    • alpha tocopherol
  • weight loss therapy
    • orlistat
    • gastric bypass
  • for diabetics- insulin sensitiser
    • metformin
  • antihyperlipidaemic drugs
    • gemfibrozil
  • if end stage liver disease- transplant
107
Q

What is the prognosis for patients with NASH?

A

NASH is a progressive form of non-alcoholic liver disease

Therefore NASH has worse prognosis- 10-20% of patients progress to fibrosis

1/3rd of these will progress to liver failure and transplant

Recurrent NASH following liver transplantation is common

108
Q

Define cirrhosis

A

Diffuse pathological process arising from a variety of causes , characterised by:

  1. fibrosis
  2. conversion of normal liver architecture to structurally abnormal regenerative nodules

Cirrhosis is the final stage of any chronic liver disease.

IRREVERSABLE

109
Q

What is meant by decompensated cirrhosis?

A

Acute deterioration in liver function with portal hypertension in a patient with cirrhosis

Characterised by:

  • jaundice
  • ascites
  • hepatic encephalopathy
  • variceal haemorrhage
110
Q

List some factors that can trigger decompensated cirrhosis

A
  • infection
  • GI bleeding
  • constipation
  • high-protein meal
  • electrolyte imbalances
  • alcohol and drugs
  • tumour development
  • portal vein thrombosis
111
Q

List the most common causes of cirrhosis in the Western world:

A
  • alcohol-related liver disease
  • non-alcoholic fatty liver disease (NAFLD and associated steatohepatitis)
  • chronic viral hepatitis B/C (with or without coexisting hepatitis D)
112
Q

List the causes of cirrhosis

A
  1. chronic viral heptatitis B/C
  2. NASH
  3. alcoholic liver disease
  4. autoimmune hepatitis
  5. metabolic disorders: haemochromatosis, Wilson’s disease, alpha-1 antitrypsin deficiency
  6. cholestatic disease: primary sclerosing and primary biliary cholangitis
  7. Biliary obstruction- mechanical, atresia, CF
  8. Hepatic venous outflow obstruction- right HF, Budd-Chiari
  9. Drugs/toxins- amiodarone, methotrexate
  10. Cryptogenic cirrhosis = unknown cause
113
Q

List some inherited causes of cirrhosis

A
  • a1-antitrypsin deficiency
  • Haemochromatosis
  • Wilson’s disease – autosomal recessive condition characterised by excess copper
  • Galactosaemia
  • Cystic Fibrosis
114
Q

Summarise the epidemiology of cirrhosis

A

Liver disease = 3rd biggest cause of mortality worldwide

115
Q

What are the presenting signs and symptoms of cirrhosis?

A
  • abdominal distension w/shifting dullness-
    • from ascites due to portal hypertension
  • Haematemesis + meleana -
    • from GO varices
  • skin features:
    • jaundice and pruritus
    • impaired hepatic secretion of conjugated bilirubin and bile
  • hand and nail features:
    • leukonychia, palmar erythema, spider naevi, dupuytrens contracture
  • facial features:
    • telangiectasia, jaundiced sclera
  • abdominal features:
    • collateral circulation (caput medusae), hepatosplenomegaly, hair loss
  • peripheral features:
    • ​sarcopenia
    • peripheral oedema
116
Q

What blood/serological investigations would be done for cirrhosis?

A

Bloods

  • FBC- microcytic anaemia, thrombocytopaenia ( due to hypersplenism)
  • LFT- high ALT, AST, ALP, gamma-GT + bilirubin, low albumin
  • U+Es- hyponatraemia
  • Clotting- increased PTT,
  • Tumour markers- AFP

Investigating cause

  • Iron, TIBC, transferrin saturation, ferritin (haemachromotosis)
  • HBsAg + IGg antibodies to HCV - viral hepatitis
  • ANA + anti smooth muscle antibodies- autoimmune hepatitis
  • plasma alpha 1 antitrypsin
117
Q

What imaging investigations would you do for cirrhosis?

A

Abdo USS- signs of advanced cirrhosis, PH, ascites, increased portal vein diameter

Abdo CT/MRI- as above.

Gastroesophageal duodenoscopy- for varices

Biopsy- most specific + sensitive diagnostic test- confirmatory

With strong clinical evidence, imaging alone is sufficient for diagnosis of cirrhosis

118
Q

Explain 2 grading systems to estimate the prognosis in cirrhosis

A

Child-Pugh score + end stage liver disease :

Stage 1

  • without GO varicies or ascites
  • 1% mortality p/a

Stage 2

  • GO varices but no bleeding + no ascites
  • 4% mortality p/a

Stage 3

  • ascites +/- GO varices but no bleeding
  • 20% mortality p/a

Stage 4

  • GI bleeding due to portal hypertension +/- ascites
  • 57% mortality p/a
119
Q

How is cirrhosis managed?

A
  • Resuscitation - ABC
  • Treat underlying cause of liver failure and prevent further hepatic damage- alcohol, drugs, good nutrition
  • Monitor - vital signs, PT, pH, creatinine, urine output, encephalopathy

Manage:

  • Encephalopathy: lactulose and phosphate enemas
  • Antibiotic and antifungal prophylaxis
  • Hypoglycaemia treatment
  • sodium restriction for ascites
    • ​spironolactone + furosemide
  • Coagulopathy treatment - IV vitamin K, FFP, platelet infusions
  • Gastric mucosa protection - PPIs or sucralfate
  • AVOID sedatives or drugs metabolised by the liver
120
Q

What are the possible complications of cirrhosis?

A
  • Portal hypertension with ascites
  • Hepatic encephalopathy
  • Variceal haemorrhage
  • SBP- spontaneous bacterial peritonitis
  • HCC
  • Renal failure (hepatorenal syndrome)
  • Pulmonary hypertension (hepatopulmonary syndrome)
  • Hepatic hydrothorax
121
Q

Summarise the prognosis for patients with cirrhosis

A

Depends on aetiology and complications

Generally poor prognosis

  • Overall 5 year survival = 50%
  • If ascites, 2 year survival = 50%

Poor prognostic indicators:

  • encephalopathy
  • serum Na+ <110 mmol/L
  • serum albumin <25g/L
  • high INR
122
Q

Define portal hypertension

A

Abnormally high pressure within the hepatic portal vein.

Clinically significant portal hypertension is defined as a hepatic venous pressure gradient > 10 mmHg

123
Q

Explain the aetiology/pathophysiology of portal hypertension due to cirrhosis

A

Pressure within portal venous system is dependent on:

  1. input from blood flow in the portal vein
    • sodium retention + vasoactive NO increase (buildup of toxic metabolites)
    • → increased plasma volume + splanchnic vasodilation
  2. hepatic resistance to outflow
    • Vascular channels go smooth → tortuous + irregular (collagen depositions and fibrosis)
    • → increased resistance to flow
    • → increased pressure → varices and dilations
124
Q

State the pre-hepatic cuases of portal hypertension

A
  • Splenic/ portal vein thrombosis (sepsis, trauma)
  • Congenital stenosis
  • Extrinsic compression eg by tumour
125
Q

State the hepatic causes of portal hypertension

A
  • CIRRHOSIS
  • Schistomiasis
  • Sarcoidosis + hepatic granulomas
  • Myeloproliferative disease (CML/polycythaemia vera/essential thrombocytaemia)
126
Q

State some post-hepatic causes of portal hypertension

A

Anything causing HEPATIC VENOUS OUTFLOW OBSTRUCITON

  • Budd-Chiari syndrome (obstructing lesions of the hepatic veins and IVC)
  • Constrictive pericarditis
  • Tricuspid regurgitation
  • Right heart failure (congestive cardiac)
127
Q

What are the presenting symptoms of portal hypertension?

A
  • splenomegaly, hepatomegaly
  • ascites
  • jaundice
  • stigmata- spider naevi, caput medusae, umbilical hernia
  • peripheral oedema
  • gynaemcomastia
  • GI varices - malaena, haemetemesis (may present with this)
  • Encephalopathy- lethargy, irritability, disturbed sleep
128
Q

What investigations would you do for portal hypertension?

A

In advanced disease, diagnosis can be clinical (ascites, varices)

Bloods

  • LFTs- thrombocytopaenia, hypoalbuminaemia, microcytic anaemia
  • Clotting- prolonged PTT- EARLY SIGN
  • specific serological tests for the underlying cause

Imaging

  • Doppler USS- increased hepatic echogenicity, splenomegaly, HPV dilation, occlusions, gallbladder thickening
  • Endoscopy- in cases of GI haemorrhage. Visualise varices.
129
Q

How is portal hypertension managed?

A

Aimed at prevention of complications by decreasing portal pressures.

Pharmacotherapy

  • Beta-blockers eg propanolol
    • reduce risk of variceal bleeding- only use if present
  • Somatostatin + vasopressin/terlipressin
    • acute bleeding of varices
    • vasoconstrictors of splanchnic beds
  • Prophylactic antibiotics

Treating varices/GI haemorrhage

  • Sclerotherapy
  • Oesophageal band ligation
  • Balloon Tamponade

Transjugular Intrahepatic Portosystemic Shunt (TIPSS)

Indicated in patients who have had recurrent bleeding despite medical or endoscopic management

Main side effect is hepatic encephalopathy + thrombosis

Liver transplant

Only effective treatment for end-stage liver disease.

130
Q

Explain how varices develop

A

Varices develop when portal blood is rerouted to the systemic circulation, through collateral vessels

Due to increased resistance to blood flow to/through the liver.

The pressure within these irregular vessels is great and they have the potential to rupture.

131
Q

How is ascites managed?

A
  • Potassium sparing (spironolactone) and loop (furosemide) diuretics
  • sodium restriction
  • paracentesis if poorly controlled with above
132
Q

What are the complications of portal hypertension?

A
  • Variceal bleeding
  • Ascites
  • Hepatopulmonary syndrome
    • hepatic dysfunction
    • hypoxaemia
    • extreme intrapulmonary vasodilation
  • Hepatic hydrothorax
    • pleural effusion for hepatic reasons (i.e. no cardiac, pulmonary, or pleural disease)
  • Hepatorenal syndrome
    • rapid decline in kidney function (see diagram)
  • Complications of liver failure- encephalopathy,
133
Q

Summarise the prognosis for patients with portal hypertension

A

Depends on the underlying CAUSE

Variceal haemorrhages have a 1-year mortality of 40%

134
Q

What are some causes of ascites?

A
135
Q

Define liver failure (both acute and acute-chronic)

A

Rapid decline in hepatic function characterised by:

  • jaundice
  • coagulopathy (INR >1.5)
  • hepatic encephalopathy
  • acute/fulminant* = patients with no prior liver disease
  • acute-on-chronic* = acute decompensation of chronic liver disease
136
Q

How is liver failure classified?

A

It is classified based on the time interval between the onset of jaundice and the development of hepatic encephalopathy

  • Hyperacute = < 7 days
  • Acute = 1-4 weeks
  • Subacute = 4-12 weeks

There is decreasing risk of cerebral oedema with increased delay of encephalopathy

137
Q

State some common causes of acute liver failure

A

ALF

  • 66% = paracetamol hepatotoxicity
  • 11% = idiosyncratic drug reactions e.g. antimicrobials
  • Hepatitis B, A, autoimmune, ischaemic

Acute on Chronic

  • Anything condition causing liver injury, in combination with precipitating factors eg infection, GI bleeding, constipation
  • eg Budd Chiari, ALD, NASH, HCC
138
Q

Explain the pathogenesis of hepatic encephalopathy

A
  1. Ammonia is absorbed in the gut and enters the enterohepatic circulation
  2. Impaired liver function leads to impaired ammonia clearance + cirrhosis leads to portosystemic shunting → absorbed into blood
  3. Hyperammonaemia causes brain dysfunction as NH3 crosses the BBB and acts as a neurotoxin
  4. NH3 converted to glutamine in astrocytes causing swelling and oedema
139
Q

Explain the pathogenesis of coagulopathy in ALF

A

Liver plays a central function in haemostasis

Impaired liver function leads to:

  • platelet dysfunction
  • reduced synthesis + increased consumption of clotting factors
  • reduced clearance of activated factors
140
Q

Summarise the epidemiology of liver failure

A

in UK, 66% paracetamol overdose

Worldwide, viral infection accounts for majority of ALF - HEV + HBV

141
Q

What are the presenting symptoms of ALF?

A
  • RUQ pain
  • N+V
  • jaundice
    • defining feature of ALF
  • malaise
  • signs of hepatic encephalopathy + cerebral oedema
    • defining feature of ALF
  • hepatomegaly but NO splenomegaly
  • NO stigmata of chronic liver disease
  • NO ascites
142
Q

What blood investigations would you do for ALF?

A
  • Clotting screen- increased PTT, INR>1.5 =DEFINING FEATURE
  • LFTs- hyperbilirubinaemia, elevated liver enzymes
  • U+Es- metabolic derangements, high urea and creatine
  • FBC- leukocytosis (if infection), anaemia, thrombocytopaenia
  • bloodgroup and save- prepare for transplant
  • ABG- metabolic acidosis (high lactate) in paracetamol overdose

identify cause:

  • toxicology- if overdose suspected
  • viral serology- HBcIgM
  • autoimmune markers- ANA, ASMA
  • Caeruloplasmin and urinary copper (Wilson’s disease)
143
Q

What non-bedside investigations would you do for ALF?

A
  • Liver US/CT
  • Ascitic Tap
    • Send for MC&S
    • If neutrophils > 250/mm3 = spontaneous bacterial peritonitis
  • Doppler scan of hepatic or portal veins - check for Budd-Chiari syndrome
  • EEG +/- CT head - monitor encephalopathy
144
Q

How is ALF managed?

A
  • Monitoring-
    • blood glucose, electrolytes, cultures
      • coagulopathy - ​IV vitamin K, FFP, platelet infusions
    • neurological status for encephalopathy
      • manage = lactulose and phosphate enemas
      • decrease ICP with mannitol
  • Treat cause-
    • acetylcysteine- paracetamol overdose
    • autoimmune heptitis- methylprednisolone
    • HBV- nucleoside/tide analogue- TDF, entecavir
    • Budd Chiarri- anticoagulation (LMWH) + TIPSS
  • Liver transplant
145
Q

What are the criteria for a liver transplant?

A
  • >18yrs
  • life expectancy <7days w/o
  • <8 weeks between onset and encephalopathy
  • ITU admission
  • plus one of:
    • ventilator dependence
    • requirement of renal replacement therapy
    • INR >2.0.
146
Q

Identify the possible complications of liver failure

A
  • rapidly progressing hepatic encephalopathy
    • high risk of cerebral oedema (up to 75%)
  • coagulopathy
    • risk of acute bleeding quite low
  • infection
    • primary cause of mortality
    • bacterial infections in >80% ALF cases
  • renal failure and haemodynamic changes
  • metabolic disorders
    • acid base distrubances
    • electrolyte imbalances
  • cerebral oedema
    • primary cause of mortality
  • gastrointestinal bleeding
    • due to coagulopathy and the requirement for mechanical ventilation
    • give PPIs prophylactically
147
Q

what is the prognosis of ALF?

A

Most important prognostic indicator in ALF is aetiology

ALF 2/2 paracetamol overdose, acute HAV, or ischaemic liver injury = favourable prognosis

ALF 2/2 idiosyncratic drug-induced liver injury, acute HBV, Wilsons’ or indeterminate = lower rate of spontaneous recovery

148
Q

Define haemochromotosis

A

Autosomal recessive multisystem disorder of dysregulated dietary iron absorption and increased iron release from macrophages.

Leads to accumulation in multiple organs- liver, heart, ant. pituitary, joints etc

damage + fibrosis

149
Q

Explain the aetiology of haemochromotosis

A
  • Hereditary- HFE gene = >90% cases
  • Autosomal recessive disorder in white populations
150
Q

What is the epidemiology of haemochromotosis?

A

Rare

Presents in middle age- symptoms occur when there has been significant iron accumulation

Presents later in women- menstruation is protective

151
Q

What are the symptoms of haemochromotosis?

A

Early symptoms:

  • malaise
  • atrophy
  • ED
  • heart problems

Late symptoms:

  • bronzed skin
  • amenorrhoea
  • hypogonadism, impotence
  • cirrhosis
  • neurological/psychiatric problems
152
Q

Identify appropriate investigations to diagnose haemochromatosis

A

Haematinics:

  • serum transferrin saturation- high. First test to become abnormal
  • serum ferritin- high
    • acute phase protein- raised in inflammation, alcoholism, viral hepatitis, NAFLD
    • checks magnitude of iron overload

genetic testing:

  • HFE mutation analysis
  • confirm diagnosis
153
Q

Identify appropriate investigations in haemochromatosis to assess degree of iron deposition?

A
  • Liver MRI- non-invasive way to estimate liver iron content
  • Liver biopsy- most sensitive and specific test for measuring liver iron content and evaluate liver injury (fibrosis, cirrhosis)
  • Fasting blood sugar- to assess damage to the pancreas from iron overload
  • ECG and echocardiogram: check for cardiomyopathy and conduction abnormalities → arrhythmias
  • Sex hormones- check for hypogonadism
154
Q

Wilson’s disease

A

An autosomal recessive disorder characterised by reduced biliary excretion of copper and accumulation of copper in the liver and brain, especially in the basal ganglia.

Also known as hepatolenticular degeneration.

155
Q

What is the aetiology of Wilson’s disease?

A

Mutation in the ATP7B gene, which is part of the biliary excretion of copper by hepatocytes

Interference with the transport of copper by ATPases into hepatocyte compartments

Therefore no incorporation into caeruloplasmin or bile excretion

Excess copper damages the hepatocyte mitochondria → necrosis and copper release into plasma

156
Q

Summarise the epidemiology of Wilson’s disease

A
  • Liver disease may present in children
  • Neurological disease usually presents in young adults
  • The disease does not favour a particular sex and all ethnic groups are affected equally.
157
Q

Recognise the presenting symptoms of Wilson’s disease

A

May present with hepatitis, liver failure, cirrhosis (and associated symptoms- jaundice, ascites, oedema)

  • Kayser-Fleischer Rings – visible to naked eye in late stages, early stages seen by slit lamp
  • behavioural abnormalities
    • delusions, loss of emotional control, memory loss, depression
  • dysarthria, dystonia
    • speech may be slow/slurred
  • incoordination, dysdiadochokinesis, tremor
    • sloppy or small handwriting
    • can’t alternate hands from prone to supine
  • abnormal extraocular movements
    • saccadic movements, esotropia, diplopia
158
Q

Identify appropriate investigations for Wilson’s disease

A
  • LFTs: high AST, ALT, ALP
  • FBC- thrombocytopaenia, low WCC
  • Low serum caeruloplasmin
    • acute phase protein- may give false-negatives in inflammation/chronic liver disease/pregnancy
  • Serum copper
  • 24 hour urinary copper - high
  • Slit-lamp exam- KF rings
  • Liver biopsy - increased copper content
  • Genetic analysis - ATP7B mutations
  • MRI head – degeneration in basal ganglia, fronto-temporal, cerebellar and brainstem
159
Q
A
160
Q
A
161
Q
A